The use of complementary and alternative therapies to treat anxiety and depression in the United States.

OBJECTIVE This study presents data on the use of complementary and alternative therapies to treat anxiety and depression in the United States. METHOD The data came from a nationally representative survey of 2,055 respondents (1997-1998) that obtained information on the use of 24 complementary and alternative therapies for the treatment of specific chronic conditions. RESULTS A total of 9.4% of the respondents reported suffering from "anxiety attacks" in the past 12 months; 7.2% reported "severe depression." A total of 56.7% of those with anxiety attacks and 53.6% of those with severe depression reported using complementary and alternative therapies to treat these conditions during the past 12 months. Only 20.0% of those with anxiety attacks and 19.3% of those with severe depression visited a complementary or alternative therapist. A total of 65.9% of the respondents seen by a conventional provider for anxiety attacks and 66.7% of those seen by a conventional provider for severe depression also used complementary and alternative therapies to treat these conditions. The perceived helpfulness of these therapies in treating anxiety and depression was similar to that of conventional therapies. CONCLUSIONS Complementary and alternative therapies are used more than conventional therapies by people with self-defined anxiety attacks and severe depression. Most patients visiting conventional mental health providers for these problems also use complementary and alternative therapies. Use of these therapies will likely increase as insurance coverage expands. Asking patients about their use could prevent adverse effects and maximize the usefulness of therapies subsequently proven to be effective.

[1]  E. Klieser,et al.  [Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study]. , 2000, Fortschritte der Neurologie-Psychiatrie.

[2]  J. Falloon,et al.  Indinavir concentrations and St John's wort , 2000, The Lancet.

[3]  Adriane Fugh-Berman,et al.  Herb-drug interactions , 2000, The Lancet.

[4]  E. Ernst,et al.  Second thoughts about safety of St John's wort , 1999, The Lancet.

[5]  E. Ernst,et al.  Hypericum for depression An update of the clinical evidence , 1999, European Neuropsychopharmacology.

[6]  J. Davidson,et al.  Alternative therapy use by psychiatric outpatients. , 1999, The Journal of nervous and mental disease.

[7]  J. Yager,et al.  Use of alternative remedies by psychiatric patients: illustrative vignettes and a discussion of the issues. , 1999, The American journal of psychiatry.

[8]  B. Druss,et al.  Association between use of unconventional therapies and conventional medical services. , 1999, JAMA.

[9]  R. Kessler,et al.  Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. , 1999, The American journal of psychiatry.

[10]  J. Astin.  Why Patients Use Alternative Medicine—Reply , 1998 .

[11]  L. Baldwin.  Why patients use alternative medicine. , 1998, JAMA.

[12]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[13]  H. Boon,et al.  Herbal remedies in psychiatric practice. , 1998, Archives of general psychiatry.

[14]  J. Röschke,et al.  [Adjuvant whole body acupuncture in depression. A placebo-controlled study with standardized mianserin therapy]. , 1998, Der Nervenarzt.

[15]  J. Astin.  Why patients use alternative medicine: results of a national study. , 1998, JAMA.

[16]  D. Landers,et al.  THE EFFECT OF EXERCISE ON CLINICAL DEPRESSION: A META-ANALYSIS , 1998 .

[17]  J. Blumenthal,et al.  Exercise training as an alternative treatment for depression among older adults. , 1998, Alternative therapies in health and medicine.

[18]  W. Haskell,et al.  Current Trends in the Integration and Reimbursement of Complementary and Alternative Medicine by Managed Care, Insurance Carriers, and Hospital Providers , 1997, American journal of health promotion : AJHP.

[19]  M. Hazzard.  Klaus Linde, Gilbert Ramirez, Cynthia D. Mulrow, Andrej Pauls, Wolfgang Weidenhammer, and Dieter Melchart. (1996). St. John's wort for depression—An overview and meta-analysis of randomized clinical trials. British Medical Journal, 313, 3 August 1996, 253-8 , 1997 .

[20]  L. Paramore.  Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey. , 1997, Journal of pain and symptom management.

[21]  H. Volz,et al.  Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial. , 1997, Pharmacopsychiatry.

[22]  J. Almeida,et al.  Coma from the Health Food Store: Interaction between Kava and Alprazolam , 1996, Annals of Internal Medicine.

[23]  E. Lehmann,et al.  Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin - A double-blind placebo-controlled study of four weeks treatment. , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[24]  P. Shekelle,et al.  The effect of cost sharing on the use of chiropractic services. , 1996, Medical care.

[25]  C. Mulrow,et al.  St John's wort for depression—an overview and meta-analysis of randomised clinical trials , 1996, BMJ.

[26]  R. Carney,et al.  Cognitive Behavior Therapy, Relaxation Training, and Tricyclic Antidepressant Medication in the Treatment of Depression , 1995, Psychological reports.

[27]  J. Kabat-Zinn,et al.  Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. , 1995, General hospital psychiatry.

[28]  R. Kessler,et al.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use. , 1993, The New England journal of medicine.

[29]  E. Lehmann,et al.  [Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks]. , 1991, Arzneimittel-Forschung.

[30]  G. Warnecke.  [Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490]. , 1991, Fortschritte der Medizin.

[31]  J. Yager,et al.  Help seeking and satisfaction with care in 641 women with eating disorders. I. Patterns of utilization, attributed change, and perceived efficacy of treatment. , 1989, The Journal of nervous and mental disease.

[32]  W. Reynolds,et al.  A comparison of cognitive-behavioral therapy and relaxation training for the treatment of depression in adolescents. , 1986, Journal of consulting and clinical psychology.

[33]  L. Kish,et al.  Inference from Complex Samples , 1974 .